These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 39343084)

  • 1. Immunopathogenesis of systemic lupus erythematosus: An update.
    Arnaud L; Chasset F; Martin T
    Autoimmun Rev; 2024 Oct; 23(10):103648. PubMed ID: 39343084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus.
    Pierdominici M; Vomero M; Barbati C; Colasanti T; Maselli A; Vacirca D; Giovannetti A; Malorni W; Ortona E
    FASEB J; 2012 Apr; 26(4):1400-12. PubMed ID: 22247332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of systemic lupus erythematosus-an update.
    Choi J; Kim ST; Craft J
    Curr Opin Immunol; 2012 Dec; 24(6):651-7. PubMed ID: 23131610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic lupus erythematosus: from pathophysiology to treatment].
    Contin-Bordes C; Lazaro E; Pellegrin JL; Viallard JF; Moreau JF; Blanco P
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H9-13. PubMed ID: 19995652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in mechanisms of systemic lupus erythematosus.
    Dema B; Charles N
    Discov Med; 2014 May; 17(95):247-55. PubMed ID: 24882716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte and macrophage abnormalities in systemic lupus erythematosus.
    Li Y; Lee PY; Reeves WH
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):355-64. PubMed ID: 20676786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus.
    Gatto M; Depascale R; Stefanski AL; Schrezenmeier E; Dörner T
    Best Pract Res Clin Rheumatol; 2023 Dec; 37(4):101864. PubMed ID: 37625930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose binding lectin (MBL) in autoimmunity and its role in systemic lupus erythematosus (SLE).
    Pradhan V; Surve P; Ghosh K
    J Assoc Physicians India; 2010 Nov; 58():688-90. PubMed ID: 21510462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus.
    Suggs MJ; Majithia V; Lewis RE; Cruse JM
    Exp Mol Pathol; 2011 Oct; 91(2):548-62. PubMed ID: 21497601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Immunogenetic Aspects of Systemic Lupus Erythematosus.
    Bhaskar LVKS; Nagaraju GP
    Crit Rev Immunol; 2019; 39(5):343-360. PubMed ID: 32422016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus.
    Lo MS
    Front Immunol; 2018; 9():1278. PubMed ID: 29922296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in understanding the role of type I interferons in systemic lupus erythematosus.
    Crow MK
    Curr Opin Rheumatol; 2014 Sep; 26(5):467-74. PubMed ID: 25010440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.